BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30108199)

  • 1. Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy.
    Li H; Liu L; Liu C; Zhuang J; Zhou C; Yang J; Gao C; Liu G; Lv Q; Sun C
    Med Sci Monit; 2018 Aug; 24():5668-5688. PubMed ID: 30108199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
    Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
    Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.
    Yu G; Zhang Y; Ren W; Dong L; Li J; Geng Y; Zhang Y; Li D; Xu H; Yang H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():85-94. PubMed ID: 28053519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking.
    Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
    Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking.
    Chai Y; Chen F; Li Z; Yang P; Zhou Q; Liu W; Xi Y
    Clin Transl Oncol; 2023 Feb; 25(2):384-395. PubMed ID: 36369630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism of Caulis Spatholobi in the Treatment of Chronic Myeloid Leukemia based on Network Pharmacology and Experimental Verification.
    Wu Y; Lian F; Chen H; Zhang C; Wei L; Tian H
    Curr Comput Aided Drug Des; 2024; 20(1):49-59. PubMed ID: 37073142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.
    Yu G; Wang W; Wang X; Xu M; Zhang L; Ding L; Guo R; Shi Y
    BMC Complement Altern Med; 2018 Nov; 18(1):292. PubMed ID: 30382864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.
    Sheng S; Yang ZX; Xu FQ; Huang Y
    Chin J Integr Med; 2021 Feb; 27(2):106-114. PubMed ID: 32388823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
    Taha KF; Khalil M; Abubakr MS; Shawky E
    J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.
    Gan D; Xu X; Chen D; Feng P; Xu Z
    Med Sci Monit; 2019 Aug; 25():5700-5716. PubMed ID: 31368456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on mechanism of Tibetan medicine Zuomua Decoction in treatment of hypertension based on network pharmacology and molecular docking technology].
    Ba-Jia G; Yue R; Jing MA; Sang G; Jie-Ren-Qing D; Gong-Yu LI; Ma-Ci-Ren NI; Yan-Ling Z
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5383-5392. PubMed ID: 33350197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure.
    Chen L; Cao Y; Zhang H; Lv D; Zhao Y; Liu Y; Ye G; Chai Y
    J Ethnopharmacol; 2018 Jun; 219():359-368. PubMed ID: 29366769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of Qingdai compound on expression of bcr/abl and JWA in K562 cells].
    Dai HP; Shen Q; Zhou JW; Tang WY; Zhu GR; Xia W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):809-11. PubMed ID: 16277847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
    Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
    Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
    Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.